Our Story
Stevenage Bioscience Catalyst was formed through a collaboration between the Department for Business, Energy and Industrial Strategy (BEIS), GlaxoSmithKline, Wellcome and Innovate UK.
This has created a globally recognised cluster for therapeutic research and development that provides support for translation and commercialisation of innovative new medicines.
History
Stevenage Bioscience Catalyst was formed through a collaboration between the Department for Business, Energy and Industrial Strategy (BEIS), GlaxoSmithKline, Wellcome and Innovate UK.
This has created a globally recognised cluster for therapeutic research and development that provides support for translation and commercialisation of innovative new medicines.
Vision and Mission
Vision
A world class cluster of excellence that accelerates the translation of innovative science and technology to improve the health and quality of people’s lives.
Mission
To create a globally recognised vibrant life science ecosystem that brings together academics and entrepreneurs with growing and established healthcare companies in the spirit of collaboration and partnership.
Stevenage Bioscience Catalyst will achieve this by providing networks, support and expertise to enable them to connect, grow and succeed in the development and commercialisation of life changing interventions.
Vision and Mission
Vision
A world class cluster of excellence that accelerates the translation of innovative science and technology to improve the health and quality of people’s lives.
Mission
To create a globally recognised vibrant life science ecosystem that brings together academics and entrepreneurs with growing and established healthcare companies in the spirit of collaboration and partnership.
Stevenage Bioscience Catalyst will achieve this by providing networks, support and expertise to enable them to connect, grow and succeed in the development and commercialisation of life changing interventions.
The SBC team have been instrumental, not just in infrastructure access but in fostering a network of founders and investors. If you’ve got an idea, and you’re looking for a place to be, come to Stevenage.
Pedro Correa de Sampaio PhD, Neobe Therapeutics, CEO and Co-founder
Award Winning
“The SBC team have been instrumental, not just in infrastructure access but in fostering a network of founders and investors. If you’ve got an idea, and you’re looking for a place to be, come to Stevenage.”
Pedro Correa de Sampaio PhD, Neobe Therapeutics, CEO and Co-founder
Future
In 2023, planning was approved for UBS Asset Management to build a 1.6mn sq ft science park called Elevate Quarter, set to be one of the largest in Europe, onto the Stevenage campus. This expansion project will provide space for companies to scale and create 5,000 additional jobs over the next decade.
